Market capitalization | $336.80m |
Enterprise Value | $334.55m |
P/E (TTM) P/E ratio | 33.67 |
EV/FCF (TTM) EV/FCF | 95.31 |
EV/Sales (TTM) EV/Sales | 1.56 |
P/S ratio (TTM) P/S ratio | 1.57 |
P/B ratio (TTM) P/B ratio | 2.70 |
Revenue growth (TTM) Revenue growth | 26.22% |
Revenue (TTM) Revenue | $214.30m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
3 Analysts have issued a Viemed Healthcare Inc forecast:
3 Analysts have issued a Viemed Healthcare Inc forecast:
Sep '24 |
+/-
%
|
||
Revenue | 214 214 |
26%
26%
|
|
Gross Profit | 128 128 |
25%
25%
|
|
EBITDA | 41 41 |
23%
23%
|
EBIT (Operating Income) EBIT | 17 17 |
23%
23%
|
Net Profit | 10 10 |
13%
13%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Viemed Healthcare, Inc. engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment that provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore on December 14, 2016 and is headquartered in Lafayette, LA.
Head office | Canada |
CEO | Casey Hoyt |
Employees | 996 |
Founded | 2006 |
Website | www.viemed.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.